1. Home
  2. RGNT vs ALAR Comparison

RGNT vs ALAR Comparison

Compare RGNT & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.74

Market Cap

14.3M

Sector

Health Care

ML Signal

N/A

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

N/A

Current Price

$1.60

Market Cap

13.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
RGNT
ALAR
Founded
2004
2013
Country
Israel
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
14.3M
13.1M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
RGNT
ALAR
Price
$1.74
$1.60
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $16.00
AVG Volume (30 Days)
42.0K
★ 135.1K
Earning Date
09-11-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$24.89
Revenue Next Year
N/A
$26.13
P/E Ratio
★ N/A
$44.31
Revenue Growth
N/A
N/A
52 Week Low
$1.23
$1.16
52 Week High
$15.50
$16.56

Technical Indicators

Market Signals
Indicator
RGNT
ALAR
Relative Strength Index (RSI) 38.13 40.27
Support Level $1.23 $1.16
Resistance Level $2.48 $2.10
Average True Range (ATR) 0.11 0.15
MACD -0.02 -0.02
Stochastic Oscillator 7.27 11.32

Price Performance

Historical Comparison
RGNT
ALAR

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.

Share on Social Networks: